Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207881943> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3207881943 endingPage "iv17" @default.
- W3207881943 startingPage "iv17" @default.
- W3207881943 abstract "Abstract Aims Tumour Treating Fields (TTF) in combination with standard therapy, prolongs survival in patients with Glioblastoma (GBM). The aim of the current study was to assess the feasibility of integrating TTF into a standard UK neuro-oncology service with a focus on patient tolerability, compliance, and treatment delivery. Method A prospective study was performed of UK patients with IDH 1 Wild Type, MGMT Unmethylated GBM treated with TTF, in conjunction with conventional therapy. Patient compliance data, device-specific tolerability questions, and an evaluation of disease progression and survival were collected. Monthly quality of life (QoL) questionnaires (EORTC QLQ-C30 with BN-20) examined the trend of global health, psychosocial function and symptom progression. Results Nine patients were enrolled with a median age of 47 (7 males; 2 females). Overall, compliance with TTF was 89% (range 16% - 97%). Only one patient failed to comply with treatment. Patients tolerated the device with minimal side effects. Eight patients described mild to moderate skin irritation, whilst all patients were keen to recommend the device to other patients (100%). Most patients found the weight and size of the device to be its biggest drawback (72%). Progression-free survival was 5.5 months and median overall survival 14.9 months. Conclusion TTF was well tolerated amongst a small cohort of UK patients, who were able to comply with treatment without any significant complication. QoL questionnaires showed no sustained deterioration in global health, physical and emotional function until the final months of life, when disease burden was greatest." @default.
- W3207881943 created "2021-10-25" @default.
- W3207881943 creator A5004277782 @default.
- W3207881943 creator A5016526278 @default.
- W3207881943 creator A5024372603 @default.
- W3207881943 creator A5026215131 @default.
- W3207881943 creator A5035488491 @default.
- W3207881943 creator A5052017818 @default.
- W3207881943 creator A5069276436 @default.
- W3207881943 creator A5079386554 @default.
- W3207881943 creator A5081098127 @default.
- W3207881943 date "2021-10-01" @default.
- W3207881943 modified "2023-09-27" @default.
- W3207881943 title "Tumour Treating Fields in Glioblastoma: Is the treatment tolerable, effective, and practical in UK Patients?" @default.
- W3207881943 doi "https://doi.org/10.1093/neuonc/noab195.043" @default.
- W3207881943 hasPublicationYear "2021" @default.
- W3207881943 type Work @default.
- W3207881943 sameAs 3207881943 @default.
- W3207881943 citedByCount "0" @default.
- W3207881943 crossrefType "journal-article" @default.
- W3207881943 hasAuthorship W3207881943A5004277782 @default.
- W3207881943 hasAuthorship W3207881943A5016526278 @default.
- W3207881943 hasAuthorship W3207881943A5024372603 @default.
- W3207881943 hasAuthorship W3207881943A5026215131 @default.
- W3207881943 hasAuthorship W3207881943A5035488491 @default.
- W3207881943 hasAuthorship W3207881943A5052017818 @default.
- W3207881943 hasAuthorship W3207881943A5069276436 @default.
- W3207881943 hasAuthorship W3207881943A5079386554 @default.
- W3207881943 hasAuthorship W3207881943A5081098127 @default.
- W3207881943 hasBestOaLocation W32078819431 @default.
- W3207881943 hasConcept C118552586 @default.
- W3207881943 hasConcept C126322002 @default.
- W3207881943 hasConcept C141071460 @default.
- W3207881943 hasConcept C150966472 @default.
- W3207881943 hasConcept C159110408 @default.
- W3207881943 hasConcept C1862650 @default.
- W3207881943 hasConcept C188816634 @default.
- W3207881943 hasConcept C197934379 @default.
- W3207881943 hasConcept C2778375690 @default.
- W3207881943 hasConcept C2779951463 @default.
- W3207881943 hasConcept C71924100 @default.
- W3207881943 hasConcept C72563966 @default.
- W3207881943 hasConceptScore W3207881943C118552586 @default.
- W3207881943 hasConceptScore W3207881943C126322002 @default.
- W3207881943 hasConceptScore W3207881943C141071460 @default.
- W3207881943 hasConceptScore W3207881943C150966472 @default.
- W3207881943 hasConceptScore W3207881943C159110408 @default.
- W3207881943 hasConceptScore W3207881943C1862650 @default.
- W3207881943 hasConceptScore W3207881943C188816634 @default.
- W3207881943 hasConceptScore W3207881943C197934379 @default.
- W3207881943 hasConceptScore W3207881943C2778375690 @default.
- W3207881943 hasConceptScore W3207881943C2779951463 @default.
- W3207881943 hasConceptScore W3207881943C71924100 @default.
- W3207881943 hasConceptScore W3207881943C72563966 @default.
- W3207881943 hasIssue "Supplement_4" @default.
- W3207881943 hasLocation W32078819431 @default.
- W3207881943 hasOpenAccess W3207881943 @default.
- W3207881943 hasPrimaryLocation W32078819431 @default.
- W3207881943 hasRelatedWork W1750836925 @default.
- W3207881943 hasRelatedWork W2006810578 @default.
- W3207881943 hasRelatedWork W2021258197 @default.
- W3207881943 hasRelatedWork W2774765706 @default.
- W3207881943 hasRelatedWork W2964260989 @default.
- W3207881943 hasRelatedWork W3128855896 @default.
- W3207881943 hasRelatedWork W3195788447 @default.
- W3207881943 hasRelatedWork W4206726953 @default.
- W3207881943 hasRelatedWork W4242832529 @default.
- W3207881943 hasRelatedWork W4245874507 @default.
- W3207881943 hasVolume "23" @default.
- W3207881943 isParatext "false" @default.
- W3207881943 isRetracted "false" @default.
- W3207881943 magId "3207881943" @default.
- W3207881943 workType "article" @default.